Outcomes of Older Adults with Non-Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation: A Mayo Clinic Cohort Analysis

•Nonrelapse mortality after autologous stem cell transplantation (ASCT) in older patients with lymphoma was low and has improved over time.•Older patients with a high Hematopoietic Cell Transplantation Comorbidity Index had inferior outcomes after ASCT. Age should not be the sole factor in determining for eligibility for ASCT.•Patients who were progression-free at 2 years (achieving PFS24) had excellent survival and low relapse, suggesting that ASCT may cure a subset of older patients with lymphoma.